Form 8-K Filing by RxSight, Inc.

RxSight, Inc. has filed a Form 8-K detailing the transition of Shelley Thunen from her role as Chief Financial Officer. The company entered into a transition and release agreement, as well as a consulting agreement with Ms. Thunen, effective upon her employment separation. These agreements are effective as of December 23, 2025, with Ms. Thunen providing transition services. The company has also stated that this leadership change does not impact its financial outlook or expectations for the full year 2025, and it remains focused on executing its strategic and operational priorities. The filing includes forward-looking statements regarding the company's future performance, subject to known and unknown risks and uncertainties.